Table II.
Clinical features of IDBC patients with or without T2DM (n=120).
| Clinical features | IDBC with T2DM (n=60) | IDBC without T2DM (n=60) | χ2 | P-value |
|---|---|---|---|---|
| Age, years | 2.155 | 0.142 | ||
| <60 | 31 | 23 | ||
| ≥60 | 29 | 37 | ||
| Menopause | 1.429 | 0.232 | ||
| Yes | 39 | 45 | ||
| No | 21 | 15 | ||
| Tumor size, cm | 6.806 | 0.009a | ||
| ≤2 | 17 | 31 | ||
| >2 | 43 | 29 | ||
| Number of nodules | 1.269 | 0.260 | ||
| 1 | 20 | 26 | ||
| ≥2 | 40 | 34 | ||
| Histopathological grade | 0.839 | 0.360 | ||
| G1-G2 | 25 | 30 | ||
| G3 | 35 | 30 | ||
| Lymphatic metastasis | 10.848 | 0.001a | ||
| No | 19 | 37 | ||
| Yes | 41 | 23 | ||
| Distant metastasis | 5.711 | 0.017a | ||
| No | 27 | 40 | ||
| Yes | 33 | 20 |
a
P<0.05. IDBC, invasive ductal breast carcinoma; T2DM, type II diabetes mellitus.